Clostridium difficile (C. diff) Infection (CDI)
The Centers for Disease Control and Prevention Nov. 6 released its annual progress report on health care-associated infections, which showed continued decreases in hospitalizations last year.
Every year, thousands of patients across the United States are impacted by the effects of hospital-onset Clostridioides difficile (C. diff) infections (HO-CDIs). In this webinar, we examine the limitations of current interventions to prevent transmission of C. diff. We also present the manner in…
The CDI Prevention Collaborative is a rigorous national change effort working to develop, test and implement sustainable and scalable best practices to reduce C. difficile infections.
Thank you for submitting your information to the CDI Prevention Collaborative. We will review and get back to you to discuss next steps.
A report highlighting key findings from STRIVE (States Targeting Reduction in Infections via Engagement) - a national initiative funded by the Centers for Disease Control and Prevention (CDC) and aimed at improving infection control practices and strengthening health care-associated infection…
- Health Care Facility Management
- Performance improvement
- Planning, Design, and Construction
- Antibiotic Stewardship
- Infection Prevention and Control
- Hospital Acquired Condition (HAC)
- Catheter-Associated Urinary Tract Infection (CAUTI)
- Clostridium difficile (C. diff) Infection (CDI)
- Central Line-Associated Bloodstream Infection (CLABSI)
- Multi-Drug Resistant Organism (MDRO)
- AHA Center for Health Innovation
In the fight against Clostridioides difficile (C. diff; formerly known as Clostridium difficile), hospitals have become
extra vigilant about rapidly diagnosing and treating infected patients.